E2F-1, Skp2 and cyclin E oncoproteins are upregulated and directly correlated in high-grade neuroendocrine lung tumors
- 30 April 2007
- journal article
- research article
- Published by Springer Nature in Oncogene
- Vol. 26 (48), 6927-6936
- https://doi.org/10.1038/sj.onc.1210499
Abstract
The transcription factor E2F-1 plays a crucial role in the control of cellular growth. We previously reported its differential pattern of expression in human lung tumors. In this study, we have investigated the relationships linking the status of E2F-1 and a mediator of its proteasomal degradation, the S-phase kinase-associated protein 2 (Skp2) F-box protein. Using immunohistochemistry in a series of 129 lung tumors of all histological types, we demonstrate that Skp2 accumulates preferentially in high-grade neuroendocrine (HGNE) lung carcinomas (86%, PPPPPP=0.0001) status in NE lung tumors. Overall, our data provide the first evidence of a direct and functional interconnection between the E2F-1, Skp2 and cyclin E oncoproteins in HGNE lung carcinomas.Keywords
This publication has 27 references indexed in Scilit:
- Skp2 Regulates Myc Protein Stability and ActivityMolecular Cell, 2003
- E2F1 pathways to apoptosisFEBS Letters, 2002
- Skp2 is oncogenic and overexpressed in human cancersProceedings of the National Academy of Sciences, 2001
- Distinct pattern of E2F1 expression in human lung tumours: E2F1 is upregulated in small cell lung carcinomaOncogene, 2001
- Human ARF binds E2F1 and inhibits its transcriptional activityOncogene, 2001
- SCF and Cullin/RING H2-Based Ubiquitin LigasesAnnual Review of Cell and Developmental Biology, 1999
- Alterations of expression of Rb, p16INK4A and cyclin D1 in non-small cell lung carcinoma and their clinical significanceThe Journal of Pathology, 1999
- SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27Nature Cell Biology, 1999
- Interaction between ubiquitin–protein ligase SCFSKP2 and E2F-1 underlies the regulation of E2F-1 degradationNature Cell Biology, 1999
- SKP1 Connects Cell Cycle Regulators to the Ubiquitin Proteolysis Machinery through a Novel Motif, the F-BoxCell, 1996